Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: A case report;Utilisation prophylactique du facteur VII activ́ recombinant dans l'h́morragie de la d́livrance par ćsarienne chez une patiente atteinte de d́ficit majeur en facteur VII : À propos d'un cas

Annales de Biologie Clinique

Volumn 69, Issue 6, 2011, Pages 713-719

  Comes, Jean François ^a   Devignes, Jean ^a   Thiebaugeorges, Olivier ^b   Briquel, Marie Elisabeth ^a   Lecompte, Thomas ^a,c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Service Grossesses à Risque   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Caesarean; Eptacop alfa; Haemorrhage of delivery; Major inherited factor VII deficiency; Recombinant activated factor VII

Indexed keywords

BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CESAREAN SECTION; CHEMOPROPHYLAXIS; DELIVERY; FEMALE; GENETICS; HOSPITALIZATION; HUMAN; LABOR COMPLICATION; METHODOLOGY; PEDIGREE; POSTOPERATIVE HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; CESAREAN SECTION; CHEMOPREVENTION; DELIVERY, OBSTETRIC; FACTOR VII DEFICIENCY; FACTOR VIIA; FEMALE; HUMANS; OBSTETRIC LABOR COMPLICATIONS; PEDIGREE; POSTOPERATIVE HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 82255167392     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2011.0623     Document Type: Article

References (12)

1. Lapecorella M, Mariani G. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Heamophilia 2008 ; 14 : 1170-5.
2. Giansily-Blaizot M, Verdier R, Biron-Adréani C, Schved JF C, Study group of FVII deficiency. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk? Haematologica 2004 ; 89 : 704-9. (Pubitemid 38828477)
3. Muleo G, Santoro R, Iannaccaro PG, Papaleo P, Leo F, Zappala D, et al. The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies. Blood Coagul Fibrinolysis 1998 ; 9 : 389-90. (Pubitemid 28294963)
4. Eskandari N, Feldman N, Greenspoon JS. Factor VII deficiency in pregnancy treated with recombinant factor VIIa. Obstet Gynecol 2002 ; 99 : 935-7. (Pubitemid 34442426)
5. Pehlivanov B, Milchev N, Kroumov G. Factor VII deficiency and its treatment in delivery with recombinant factor VII. Eur J Obstet Gynecol Reprod Biol 2004 ; 116 : 237-8. (Pubitemid 39195143)
6. Jiménez-Yuste V, Villar A, Morado M, Canales M, Hernandez MC, Sanjurjo MJ, et al. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia 2000 ; 6 : 588-90.
7. O'Rourke N, Lee C, Kodali BS, Harnett M. Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency. Can J Anaesth 2006 ; 53 : 528-9. (Pubitemid 44018373)
8. Peyvandi F, Jenkins P, Mannucci PM, Billio A, Zeinali S, Perkins SJ, et al. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost 2000 ; 84 : 250-7. (Pubitemid 30601471)
9. Hedner U. Mechanism of action of recombinant activated factor VII: an update. Semin Hematol 2006 ; 43 : S105-7.
10. Marty S, Barro C, Chatelain B, Fimbel B, Tribout B, Reynaud J, et al. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia 2008 ; 14 : 564-70. (Pubitemid 351638745)
11. Wright D, Poller L, Thomson JM, Sidebotham A, Hirst CF, Hirsch P. A longitudinal study of the factor VII rise during pregnancy. Thromb Haemost 1998 ; 79 : 328-30. (Pubitemid 28065879)
12. Gershwin ME, Gude JK. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med 1973 ; 288 : 141-2.